iRadimed Corp. (NASDAQ:IRMD) shares traded down 5.7% during trading on Thursday . The company traded as low as $17.50 and last traded at $17.61, with a volume of 85,282 shares trading hands. The stock had previously closed at $18.67.

Separately, Zacks Investment Research cut iRadimed Corp. from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 5th.

The company has a market cap of $184.73 million and a PE ratio of 24.87. The stock’s 50-day moving average price is $18.39 and its 200 day moving average price is $18.33.

iRadimed Corp. (NASDAQ:IRMD) last released its earnings results on Friday, July 29th. The company reported $0.24 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.03. The firm had revenue of $9.90 million for the quarter, compared to analysts’ expectations of $9.60 million. The firm’s quarterly revenue was up 30.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.16 EPS. Equities analysts anticipate that iRadimed Corp. will post $0.92 EPS for the current fiscal year.

In related news, Director Monty K. Allen sold 2,100 shares of iRadimed Corp. stock in a transaction on Monday, June 13th. The shares were sold at an average price of $20.44, for a total transaction of $42,924.00. Following the transaction, the director now owns 4,375 shares in the company, valued at approximately $89,425. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Steven M. Nardi sold 2,096 shares of iRadimed Corp. stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $17.11, for a total transaction of $35,862.56. Following the transaction, the vice president now owns 1,996 shares in the company, valued at approximately $34,151.56. The disclosure for this sale can be found here.

IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.